J Appl Biomed 4:123-134, 2006 | DOI: 10.32725/jab.2006.013

Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats

Jiří Kassa*, Gabriela Kunešová
Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic

Tabun (O-ethyl-N,N-dimethyl phosphoramidocyanidate) is one of the highly toxic organophosphorus compounds misused as chemical warfare agents for military as well as terroristic purposes. It differs from other highly toxic organophosphates in its chemical structure and by the fact that the commonly used antidotes (atropine in combination with an oxime) are not able to sufficiently eliminate its acute toxic effects.
The neuroprotective effects of the newly developed oximes (K027, K048) or trimedoxime in combination with atropine (atropine, K027/atropine, K048/atropine and trimedoxime/atropine mixtures) on rats poisoned with tabun at a lethal dose (270 mg/kg i.m.; 120% of LD50 value) were studied. The tabun-induced neurotoxicity was monitored using a functional observational battery and an automaticmeasurement of motor activity. The neurotoxicity of tabun was monitored at 24 hours and 7 days following tabun challenge. The results indicate that atropine alone is not able to protect rats from the lethal effects of tabun. Five non-treated tabun-poisoned rats and five tabun-poisoned rat treated with atropine alone died within 24 hours. On the other hand, atropine combined with all tested oximes allows most tabun-poisoned rats to survive within 7 days following tabun challenge. All three oximes tested combined with atropine seem to be sufficiently effective antidotes for a decrease in tabun-induced neurotoxicity in the case of lethal poisonings, although they are not able to eliminate tabun-induced neurotoxicity completely. Due to their neuroprotective effects, all the tested oximes appear to be more suitable oximes for the antidotal treatment of acute tabun exposure than the currently used oximes (pralidoxime, obidoxime, HI-6).

Keywords: neuroprotective; neurotoxicity; oxime; rat; tabun

Received: February 24, 2006; Revised: April 18, 2006; Published: July 31, 2006  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Kassa J, Kunešová G. Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats. J Appl Biomed. 2006;4(3):123-134. doi: 10.32725/jab.2006.013.
Download citation

References

  1. Bajgar J.: The Use of Chemical Weapons and Negotiations on their Ban: from History to the Present Time (in Czech). Nukleus Hradec Kralove, Czech Republic, 2006.
  2. Cabal J., Bajgar J.: Tabun - reappearance 50 years later (in Czech). Chem. Listy, 93:27-31, 1999.
  3. Cabal J., Kuca K., Kassa J.: Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol. Toxicol. 95:81-86, 2004. Go to original source... Go to PubMed...
  4. Cassel G., Karlsson L., Waara L. et al.: Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: A microdialysis study. Eur. J. Pharmacol. 332:43-52, 1997. Go to original source... Go to PubMed...
  5. Dawson R.M.: Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:317-331, 1994. Go to original source... Go to PubMed...
  6. Dohnal V., Kuca K., Jun D.: Prediction of a new broad-spectrum reactivator capable of reactivating acetylcholinesterase inhibited by nerve agents. J Appl. Biomed. 3:139-145, 2005. Go to original source...
  7. Eto M.: Organophosphorus Pesticides: Organic and Biological Chemistry. CRC Press Inc., Cleveland, USA, 1976.
  8. Frantik E., Hornychova M.: Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25, 1995.
  9. Hornychova M., Frantik E., Kubat J., Formanek J.: Neurotoxicity profile of supermethrin, a new pyrethroid insecticide. Cent. Eur. J. Publ. Health 3:210-218, 1995.
  10. Jokanovic M.: Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojvosanit. Pregl. 50:451-456, 1993.
  11. Jokanovic M., Maksimovic M., Kilibarda V. et al.: Oxime-induced reactivation of acetycholinesterase inhibited by phosphoramidates. Toxicol. Lett. 85:35-39, 1996. Go to original source... Go to PubMed...
  12. Kassa J.: Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40:803-816, 2002. Go to original source... Go to PubMed...
  13. Kassa J., Cabal J.: A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111-118, 1999a. Go to original source... Go to PubMed...
  14. Kassa J., Cabal J.: A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol. 84:41-45, 1999b. Go to original source... Go to PubMed...
  15. Kassa J., Cabal J., Kuca K.: A comparison of the efficacy of currently available oximes against tabun in rats. Biologia 60, Suppl. 17:77-79, 2005.
  16. Kassa J., Koupilova M.: The importance of anticholinergic drug selection for the neuroprotective effects of antidotes in soman-poisoned rats. Homeostasis 12:52-53, 2000.
  17. Kassa J., Krejcova G.: Neuroprotective effects of currently used antidotes in tabun-poisoned rats. Pharmacol. Toxicol. 92:258-264, 2003. Go to original source... Go to PubMed...
  18. Kassa J., Kuca K., Cabal J., Paar M.: A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J. Toxicol. Environ. Health 69, 2006, in press. Go to original source... Go to PubMed...
  19. Kassa J., Kunesova G.: A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. J. Appl. Toxicol. 26, published online 21. March 2006. Go to original source... Go to PubMed...
  20. Kuca K., Bielavsky J., Cabal J., Bielavska M.: Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 44:3123-3125, 2003a. Go to original source...
  21. Kuca K., Bielavsky J., Cabal J., Kassa J.: Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13:3545-3547, 2003b. Go to original source... Go to PubMed...
  22. Kuca K., Kassa J.: A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 18:529-535, 2003. Go to original source... Go to PubMed...
  23. Kuca K., Kassa J.: In vitro reactivation of acetylcholinesterase using the oxime K027. Vet. Hum. Toxicol. 46:15-18, 2004.
  24. Marrs T.C.: Organophosphate poisoning. Pharmacol. Ther. 58:51-66, 1993. Go to original source... Go to PubMed...
  25. McDonough J.H.Jr., Zoeffel L.D., McMonagle J. et al.: Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea-pigs. Epilepsy Res. 38:1-14, 2000. Go to original source... Go to PubMed...
  26. Moser V.C., Tilson H., McPhail R.C. et al.: The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929-938, 1997.
  27. Ohtomi S., Takase M., Kumagai F.: Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int. Rev. Arm. Ser. 69:97-102, 1996.
  28. Patocka J., Cabal J., Kuca K., Jun D.: Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus esters: in vitro kinetics and thermodynamics. J. Appl. Biomed. 3:91-99, 2005. Go to original source...
  29. Poziomek E.J., Hackley B.E., Steinberg G.M.: Pyridinium aldoximes. J. Org. Chem., 23:714-717, 1958. Go to original source...
  30. Puu G., Artursson E., Bucht G.: Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem. Pharmacol. 35:1505-1510, 1986. Go to original source... Go to PubMed...
  31. Roth Z., Josifko M., Maly V., Trčka V.: Statistical Methods in Experimental Medicine (in Czech) SZN, Czechoslovakia, 1962. Go to PubMed...
  32. Sakurada K., Matsubara K., Shimizu K. et al.: Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem. Res. 28:1401-1407, 2003. Go to original source... Go to PubMed...
  33. Taylor P.: Anticholinesterase agents. In: J. G. Hardman and L. E. Limbird (eds.): The pharmacological basis of therapeutics, McGraw Hill, NewYork, USA 1996, pp. 161-176.
  34. Worek F., Widmann R., Knopff O., Szinicz L.: Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch. Toxicol. 72:237-243, 1998. Go to original source... Go to PubMed...